Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic combined T and B cell immunodeficiency characterized by T- and B-cell lymphopenia, hypergammaglobulinemia and intermittent neutropenia. It presents with recurrent opportunistic viral, bacterial and fungal infections involving skin (cutaneous papillomatosis, molluscum contagiosum, skin abscesses, mucocutaneous candidiasis), upper and lower respiratory tract or septicemia. Other clinical features include autoimmune manifestations (autoimmune hemolytic anemia) and congenital heart defects (atrial septal defects, patent foramen ovale, mitral, triscupid and pulmonary valve insufficiency).
Features include always present findings: Recurrent bacterial infections, Verrucae, Chronic mucocutaneous candidiasis, and Recurrent viral infections and others; and common findings: Persistent EBV viremia, Sepsis, Decreased total lymphocyte count, and Recurrent pneumonia and others. 25 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 11 | Recurrent lower respiratory tract infections, Autoimmune hemolytic anemia, Recurrent bacterial infections |
STK4 function has not been fully characterized.
Combined immunodeficiency due to STK4 deficiency is caused by mutations in the STK4 gene on chromosome 20.
Genetic testing for STK4 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for combined immunodeficiency due to STK4 deficiency has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 11 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for combined immunodeficiency due to STK4 deficiency.
8 publications have been identified in PubMed for combined immunodeficiency due to STK4 deficiency. Research spans Basic Science / Preclinical (50%), Case Report / Case Series (38%), and Diagnostic / Biomarker (13%).
Lu J (2026). [PMID: 41006633](https://pubmed.ncbi.nlm.nih.gov/41006633/). *Cell Death Differ*. [Basic Science / Preclinical]
Li M (2026). [PMID: 41354902](https://pubmed.ncbi.nlm.nih.gov/41354902/). *Cell Mol Immunol*. [Basic Science / Preclinical]
Liu Y (2026). [PMID: 42119789](https://pubmed.ncbi.nlm.nih.gov/42119789/). *Immunol Lett*. [Case Report / Case Series]
Ding Y (2025). [PMID: 40783146](https://pubmed.ncbi.nlm.nih.gov/40783146/). *Cell Signal*. [Basic Science / Preclinical]
Wang Y (2025). [PMID: 40957900](https://pubmed.ncbi.nlm.nih.gov/40957900/). *Cell Discov*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:14 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about combined immunodeficiency due to STK4 deficiency
Lungs and breathing | 4 | Recurrent lower respiratory tract infections, Recurrent pneumonia, Bronchiectasis |
Heart and blood vessels | 1 | Secundum atrial septal defect |
Skin | 1 | Recurrent skin infections |
Metabolism | 1 | Recurrent fever |
Ying W (2024). [PMID: 39110273](https://pubmed.ncbi.nlm.nih.gov/39110273/). *J Clin Immunol*. [Case Report / Case Series]
El Kettani A (2024). [PMID: 39339890](https://pubmed.ncbi.nlm.nih.gov/39339890/). *Viruses*. [Case Report / Case Series]